A kind of preparation method and application of thiabendazole hapten
A thiabendazole and thiabendazole enzyme technology is applied in the fields of antigen, monoclonal antibody preparation, and thiabendazole hapten, which can solve the problems of complex and expensive instruments, cumbersome sample processing process, unsuitable for sample screening, etc. The effect of large sample volume, simple and feasible preparation method and low cost
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0031] Embodiment 1, preparation and identification of thiabendazole hapten
[0032] 1. Preparation of thiabendazole hapten
[0033] Mix 220 mg of 5-hydroxythiabendazole, 500 mg of phthalic anhydride and 2 mL of pyridine in 20 mL of dimethyl sulfoxide, stir and react at 80°C for 10 hours, evaporate the solvent, and purify by column chromatography The product shown in formula 1, i.e. monothiabendazole phthalate was obtained.
[0034] 2. Identification of thiabendazole hapten
[0035] The thiabendazole hapten prepared in step 1 was identified by NMR.
[0036] NMR see figure 2 . The spectrum showed two groups of aromatic ring signal peaks increased at about 8.0 ppm and carboxyl signal peaks increased at about 13.3 ppm, indicating that the hapten was successfully synthesized.
Embodiment 2
[0037] Embodiment 2, preparation and identification of thiabendazole artificial antigen
[0038] 1. Synthesis of thiabendazole immune antigen (TBZ-BSA)
[0039] (1) Take 10 mg of the product shown in Formula 1 and dissolve it in 1 mL of dimethylformamide;
[0040] (2) Take 50 μL of isobutyl chloroformate and stir at 4°C for 24 h to obtain reaction solution A;
[0041] (3) Weigh 50 mg of bovine serum albumin (BSA), add 3.8 mL of carbonate buffer solution with pH 9.0, fully dissolve, add reaction solution A drop by drop to the protein solution, and stir at room temperature for 24 h;
[0042] (4) Dialyze with 0.01mol / L phosphate buffer at 4°C for 3 days, and change the dialysate 3 times a day to remove unreacted small molecular substances;
[0043] (5) Aliquot and store at -20°C for later use.
[0044] 2. Synthesis of thiabendazole-coated antigen (TBZ-OVA)
[0045] (1) Take 10 mg of the product shown in Formula 1 and dissolve it in 1 mL of dimethylformamide;
[0046] (2) Ta...
Embodiment 3
[0052] Example 3, Preparation and Specific Identification of Enzyme-labeled Monoclonal Antibody
[0053] One, the preparation of thiabendizumab
[0054]1. Use 100 μg of the immunogen (TBZ-BSA) prepared above, dissolve the immunogen in normal saline and mix it with Freund’s complete adjuvant in an equal volume, and inject subcutaneously on the back of the neck to immunize Balb / c females aged 6-8 weeks. On the 7th, 14th, and 28th day after the initial immunization, mix the immunogen and Freund's incomplete adjuvant in equal volumes, and each additionally immunize once, and 3 days before the fusion, 100 μg of the immune complex / rat, without Freund's adjuvant Add another immunization.
[0055] 2. Proceed according to the conventional method, take the splenocytes of the immunized mice and mix them with the mouse myeloma cells (SP2 / 0) in the logarithmic growth phase, and then slowly add the preheated fusion agent (PEG4000) within 45s for fusion, Suspend evenly with HAT medium, the...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



